Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
77.60
+0.40 (0.52%)
Oct 16, 2026, 1:30 PM CST
Foresee Pharmaceuticals Market Cap
Foresee Pharmaceuticals has a market cap or net worth of 12.23 billion as of October 16, 2026. It is the 16,694th most valuable company in the world and the 646th biggest in Taiwan. Its market cap has decreased by 1.93% in one year.
Market Cap
12.23B
Enterprise Value
11.71B
Revenue
471.13M
Global Rank
Country Rank
#646 Taiwan
PE Ratio
543.44
ChartMarket Cap Chart
Since April 12, 2016, Foresee Pharmaceuticals's market cap has increased from 7.35B to 12.23B, an increase of 66.30%. That is a compound annual growth rate of 4.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 12.23B | -3.72% |
| Dec 31, 2025 | 12.70B | 5.86% |
| Dec 31, 2024 | 12.00B | -8.16% |
| Dec 29, 2023 | 13.06B | 20.98% |
| Dec 30, 2022 | 10.80B | -23.14% |
| Dec 30, 2021 | 14.05B | 34.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 24.48B |
| Handa Pharmaceuticals | 23.24B |
| TTY Biopharm Company | 20.71B |
| Synmosa Biopharma | 16.40B |
| YungShin Global Holding | 16.30B |
| ScinoPharm Taiwan | 15.78B |
| Grape King Bio | 12.98B |
| Standard Chemical & Pharmaceutical | 10.38B |